Frequency of pathologic features (%) according to the Oxford classification of IgAN patients (n = 44)
Mesangial hypercellularity . | Endocapillary hypercellularity . | Segmental glomerulosclerosis . | Tubular atrophy/interstitial fibrosis . | Crescents . | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
(M) . | (E) . | (S) . | (T) . | (C) . | |||||||
M0 | M1 | E0 | E1 | S0 | S1 | T0 | T1 | T2 | C0 | C1 | |
30 | 70 | 67 | 33 | 47 | 53 | 56 | 32 | 12 | 77 | 23 |
Mesangial hypercellularity . | Endocapillary hypercellularity . | Segmental glomerulosclerosis . | Tubular atrophy/interstitial fibrosis . | Crescents . | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
(M) . | (E) . | (S) . | (T) . | (C) . | |||||||
M0 | M1 | E0 | E1 | S0 | S1 | T0 | T1 | T2 | C0 | C1 | |
30 | 70 | 67 | 33 | 47 | 53 | 56 | 32 | 12 | 77 | 23 |
Frequency of pathologic features (%) according to the Oxford classification of IgAN patients (n = 44)
Mesangial hypercellularity . | Endocapillary hypercellularity . | Segmental glomerulosclerosis . | Tubular atrophy/interstitial fibrosis . | Crescents . | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
(M) . | (E) . | (S) . | (T) . | (C) . | |||||||
M0 | M1 | E0 | E1 | S0 | S1 | T0 | T1 | T2 | C0 | C1 | |
30 | 70 | 67 | 33 | 47 | 53 | 56 | 32 | 12 | 77 | 23 |
Mesangial hypercellularity . | Endocapillary hypercellularity . | Segmental glomerulosclerosis . | Tubular atrophy/interstitial fibrosis . | Crescents . | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
(M) . | (E) . | (S) . | (T) . | (C) . | |||||||
M0 | M1 | E0 | E1 | S0 | S1 | T0 | T1 | T2 | C0 | C1 | |
30 | 70 | 67 | 33 | 47 | 53 | 56 | 32 | 12 | 77 | 23 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.